NCT01091727View on ClinicalTrials.gov

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Neurogenic Detrusor Overactivity
Interventions
DRUG

Botulinum toxin A

Comparison of intra-detrusor injection of 300U of Botulinum toxin A versus placebo for effect on neurogenic detrusor overactivity and urinary incontinence.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT01091727 - Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity | Biotech Hunter | Biotech Hunter